Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;62(Suppl2):114-122.
doi: 10.20471/acc.2023.62.s2.16.

REVIEW ON COMPLICATIONS AND ADVERSE EFFECTS OF METALLIC URINARY STENTS

Affiliations
Review

REVIEW ON COMPLICATIONS AND ADVERSE EFFECTS OF METALLIC URINARY STENTS

Duje Rako et al. Acta Clin Croat. 2023 Jul.

Abstract

Urinary stents, be it urethral or ureteral, polymeric, metallic or biodegradable, are one of the most frequently used tools in urology and they have been used for decades in prophylactic and therapeutic setting. Although relatively low invasive, they are prone to complications and adverse effects so much that complication rates up to 100% have been described. Many reviews have focused either on specific groups of patients or particular stent types, materials or designs but so far, no comprehensive review on complications has been published. To tackle this issue, a working group was set up within ENIUS (European Network of multidisciplinary research to Improve Urinary Stents) tasked with literature search in order to screen for and systematically review published stent complications in urethra (male only) and ureters (polymeric and metallic ureteral stents in both sexes) when used in obstructed systems. In this paper, we review, catalogue and summarize complications published for metallic urethral and ureteral stents.

Keywords: Alloy; Complications; Metal; Metallic; Review; Stent; Ureteral; Ureteric; Urethral; Urinary.

PubMed Disclaimer

Similar articles

References

    1. Beysens M, Tailly TO. Ureteral stents in urolithiasis. Asian J Urol. 2018;5:274–86. 10.1016/j.ajur.2018.07.002 - DOI - PMC - PubMed
    1. Wilson CH, Rix DA, Manas DM. Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev. 2013;17:CD004925. 10.1002/14651858.CD004925.pub3 - DOI - PubMed
    1. Mangus RS, Haag BW. Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: a metanalysis. Am J Transplant. 2004;4:1889–96. 10.1111/j.1600-6143.2004.00595.x - DOI - PubMed
    1. DOI : 10.1111/j.1600-6143.2004.00595.x - DOI
    1. Mandhani A, Kappor R, Zaman W, et al. Is a 2-week duration sufficient for stenting in endopyelotomy? J Urol. 2003;169:886–9. 10.1097/01.ju.0000051341.22163.21 - DOI - PubMed

LinkOut - more resources